Abiraterone Acetate for Castrate Resistant Prostate Cancer

Clinical trial NCT01961843 · COMPLETED

Trial details

NCT number: NCT01961843
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2014-01-14
Primary completion: 2023-04-06
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.